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The PLoS Medicine Debate
B
ackground to the debate: Current guidelines recommend 
that all fever episodes in African children be treated 
presumptively with antimalarial drugs. But declining 
malarial transmission in parts of sub-Saharan Africa, 
declining proportions of fevers due to malaria, and the 
availability of rapid diagnostic tests mean it may be time 
for this policy to change. This debate examines whether 
enough evidence exists to support abandoning presumptive 
treatment and whether African health systems have the 
capacity to support a shift toward laboratory-confirmed 
rather than presumptive diagnosis and treatment of malaria 
in children under five. 
In this Viewpoint, Blaise Genton and colleagues argue in favor of 
abandoning presumptive treatment for under-fives. Mike English 
and colleagues present the opposing Viewpoint in a related article: 
English M, Reyburn H, Goodman C, Snow RW (2009) Abandoning 
presumptive antimalarial treatment for febrile children aged less than 
five years—A case of running before we can walk? PLoS Med 6(1): 
e1000015. doi:10.1371/journal.pmed.1000015
Malaria has long been the number one cause of fever 
and the leading cause of child mortality in sub-Saharan 
Africa. As a result, the World Health Organization (WHO) 
recommends treating any fever episode in African children 
with antimalarial drugs to save lives. However, this approach 
may not be as safe as it was 20 years ago for two major 
reasons. Firstly, the proportion of fevers due to malaria has 
become significantly lower, even in highly endemic areas, 
and hence the relative likelihood of missing other potentially 
fatal diseases has become higher. Secondly, we now have 
new reliable rapid diagnostic tests (RDTs) to allow proper 
diagnosis of malaria at all levels of the health system.
Evidence of Decreased Malaria Transmission in Sub-
Saharan Africa, and Declining Proportion of Fevers 
Due To Malaria
There is growing evidence documenting a substantial decline 
in malaria transmission, morbidity, and mortality in more 
than 13 African countries where malaria control interventions 
have been implemented at scale. This reduction is also 
observed in areas with previously high levels of transmission 
(e.g., [1]). Although available data are not always spatially 
congruent, and therefore cannot necessarily be viewed as 
representing secular changes, the sharp decline in sub-
Saharan Africa of the Plasmodium falciparum prevalence rate in 
children aged two to ten years—from 37% in the years 1985–
1999 to 17% in 2000–2007—clearly documents this trend 
[2]. This decrease implies that many of the areas previously 
defined as “high stable malaria transmission” have changed, 
or will soon change, into “moderate to low transmission” 
areas.
The lower the transmission, the lower the probability that 
a fever episode will be due to malaria. In Tanzania, a high-
endemicity country, only one to four out of ten under-five 
patients with fever are parasitaemic in the rural settings (A. 
M. Kabanywany, 2007 and V. D’Acremont, 2008, personal 
communications) [3]. With a decline in malaria’s prevalence, 
the hazard of misdiagnosis of many children becomes 
significant. When giving an antimalarial, the health worker is 
less likely to look for another treatable cause of fever, and this 
leads to higher morbidity and mortality due to delay in giving 
appropriate treatment, as suggested by studies that showed 
higher case fatality rates among non-malaria fevers compared 
to malaria fevers [4]. 
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Availability of RDTs for Malaria
The shift from symptom-based diagnosis to parasite-based 
management of malaria requires that clinicians have a 
reliable, easy-to-use, and inexpensive diagnostic test. It 
should have good sensitivity, require minimal training and 
equipment, and retain accuracy even after extensive storage 
under tropical conditions. All these characteristics are met 
by the new generation of RDTs. Two meta-analyses have 
clearly shown that the performance of RDTs is comparable 
to that of expert microscopy [5,6]. Appropriate action taken 
on the basis of the test result is now the key element for the 
successful introduction of RDTs. Unfortunately, this has not 
always been achieved in the implementation of RDTs so far, 
partly because the training was insufficient to change the 
clinician’s perception of malaria risk [7]. In addition, the 
ambiguous messages from WHO and national guidelines 
stating that malaria should be considered even in the 
presence of a negative test have added to the confusion [8].
At present risk levels, the risk of missing a malaria case due 
to a false-negative test is substantially smaller than the risk 
of the patient dying due to another severe disease because 
of the focus on malaria. The risk of a false-negative test and 
its potential consequences have recently been evaluated 
thoroughly in Uganda (using microscopy) [9] and in 
Tanzania (using RDTs) [10], and the safety of not treating 
malaria-negative children confirmed. 
Other compelling arguments for systematic testing are 
listed in Box 1 [11,12].
Caveat
A switch from presumptive treatment to laboratory-confirmed 
diagnosis and treatment is now urgent but needs to be 
carefully planned. Large-scale deployment of RDTs is a great 
challenge that requires theoretical and practical training, 
regular supervision, and sustained financial mechanisms to 
ensure constant availability. It is crucial that quality control is 
implemented at all steps.
Also, introduction of reliable diagnosis implies that 
clinicians need to be trained to manage the “negative 
syndrome” (patients with a negative malaria test). This is 
challenging after years of upholding the notion that fever 
equals malaria and requires substantial change in the 
behaviour of clinicians and caretakers. This is now a great 
opportunity to update and re-strengthen the Integrated 
Management of Childhood Illnesses to promote improved 
case management of African children. 
Conclusion
The recent trend of malaria decline in Africa calls for a 
shift from presumptive treatment to laboratory-confirmed 
diagnosis and treatment in all areas, regardless of age and 
level of malaria transmission. Such a move is especially 
relevant with the new momentum towards elimination 
and is now realistic thanks to reliable RDTs. As part of 
renewed malaria control efforts, it is time to improve clinical 
management and abandon irrational use of drugs, i.e., 
antimalarial treatment for no malaria and no treatment for 
other potentially fatal causes of fevers.
Genton and Colleagues’ Response to English 
and Colleagues’ Viewpoint
In this section, Genton and colleagues respond to the points raised 
by English and colleagues in their opposing Viewpoint: English 
M, Reyburn H, Goodman C, Snow RW (2009) Abandoning 
presumptive antimalarial treatment for febrile children aged less than 
five years—A case of running before we can walk? PLoS Med 6(1): 
e1000015. doi:10.1371/journal.pmed.1000015
We all agree that laboratory-confirmed diagnosis of malaria 
is the desirable goal. We disagree on the present status of 
evidence and the conditions needed to change the policy.
Evidence on RDT Performance
Evidence is accumulating showing that RDT performance 
is high, even when used in routine practice [13–15]. The 
authors of the study showing 65% sensitivity acknowledge 
themselves that “use of poor quality blood smear may impede 
reliable measurement of sensitivity and specificity and 
undermine confidence in the new diagnostic” [16]. The issue 
nowadays is no longer about RDT performance but about 
how to best implement quality assurance.
Evidence on the Safety of the Management Strategy 
Based on Laboratory Confirmation of Parasites
Although the debate about laboratory-confirmed diagnosis 
versus presumptive treatment has been ongoing for years, 
nobody has embarked on the definitive study to show that 
mortality is not higher with the former than the latter. We 
have recent evidence confirming that the strategy based 
on documented diagnosis is safe [9], even in uncontrolled 
settings [10]. We consider that accumulated experience 
in all age groups and studies including more than 3,000 
children under five are enough to decide on a policy 
change.
Evidence on Health Workers’ Beliefs and Behaviour
New evidence shows that clinicians trust and act upon 
RDT results. Indeed, in recent studies conducted under 
programmatic conditions, 2%–10% of all patients with 
negative results were given antimalarials [16] (D’Acremont 
et al., unpublished data). This contrasts with disappointing 
results published earlier [17] and illustrates the behaviour 
Box 1. Additional Arguments for a Shift from 
Presumptive Malaria Treatment to Laboratory-
Confirmed Diagnosis and Treatment According 
To Test Results in Children Under Five with Fever
sÈ 4REATINGÈALLÈFEVERÈPATIENTSÈWITHÈANTIMALARIALSÈLEADSÈTOÈAÈHUGEÈ
drug wastage, and hence potential for drug shortage 
sÈ )NAPPROPRIATEÈUSEÈOFÈANTIMALARIALSÈLEADSÈTOÈUNNECESSARYÈ
adverse drug reactions 
sÈ )RRATIONALÈUSEÈOFÈANTIMALARIALÈDRUGSÈLEADSÈTOÈINCREASEDÈPARASITEÈ
resistance
sÈ 0OTENTIALÈMISTRUSTÈONÈTHEÈPARTÈOFÈTHEÈPUBLICÈONÈTHEÈREALÈEFFICACYÈ
of artemisinin-based combination therapies (ACTs) due to use 
for inappropriate indications (viral or bacterial disease)
sÈ 0ARASITOLOGICALÈDIAGNOSISÈANDÈTREATMENTÈWITHÈ!#4SÈACCORDINGÈ
to test results versus presumptive treatment with ACTs is cost-
effective in all current malaria-endemic situations (as long as 
test result is taken into account) [11,12] PLoS Medicine  |  www.plosmedicine.org 0006 January 2009  |  Volume 6  |  Issue 1  |  e252
change that can be achieved through proper training and 
trust gained by accumulating field experience with RDTs.
To align practices in formal care settings with those at 
community level, we propose to also use RDTs outside health 
facilities. It is safe and feasible [18]. Moreover, it fits with the 
new WHO Special Programme for Research and Training 
in Tropical Diseases and UNICEF initiative that promotes 
community-integrated management of malaria/pneumonia/
diarrhoea rather than home-based management of malaria. 
More Data on Malaria Epidemiology
Improved data on local malaria epidemiology will not help 
much. We already know that heterogeneity is huge and 
rapidly evolving. Only a uniform policy across all age groups 
and epidemiological settings is likely to be implemented 
appropriately. This is best illustrated by the conclusion 
made by one of the authors of the opposing Viewpoint in 
a recent paper: “Despite different recommendations for 
patients below and above 5 years of age, malaria diagnosis 
and treatment practices were similar in the two age groups…
Malaria diagnosis recommendations differing between age 
groups appear complex to implement; further strengthening 
of diagnosis and treatment practices under AL policy is 
required.” [19].
Conclusion
We strongly believe that the policy should be changed even 
if all conditions for perfect implementation are not fulfilled. 
In areas where RDTs have been deployed at scale, clinicians 
have understood that the performance and usefulness of 
RDTs is not different in a child under five years than in an 
adult. The time needed to achieve all conditions English et 
al. consider necessary to have a policy change will only lead to 
more deaths due to diseases other than malaria left untreated 
and to the emergence of parasite resistance consequent to 
irrational use of drugs. A policy change is desirable to deliver 
clear and simple messages. Staggered implementation will 
follow according to country capacity, as is done for laboratory-
confirmed diagnosis and treatment in other age groups. 
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